Crescent Capital BDC, Inc. (CCAP): BCG Matrix

Crescent Capital BDC, Inc. (CCAP): BCG Matrix [Apr-2026 Updated]

US | Financial Services | Asset Management | NASDAQ
Crescent Capital BDC, Inc. (CCAP): BCG Matrix

Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas

Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria

Pré-Construídos Para Uso Rápido E Eficiente

Compatível com MAC/PC, totalmente desbloqueado

Não É Necessária Experiência; Fácil De Seguir

Crescent Capital BDC, Inc. (CCAP) Bundle

Get Full Bundle:
$9 $7
$9 $7
$9 $7
$9 $7
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Crescent Capital BDC's portfolio is anchored by high-yield, first‑lien leaders-notably software, healthcare tech, and expanding unitranche JV platforms-that are driving the bulk of cash flow and targeted reinvestment, while a massive, low-risk core first‑lien book funds generous distributions; smaller, high‑upside allocations to equity, mezzanine and green energy are being tested for scalable growth, and management is actively shedding underperforming legacy retail, junior tranches and distressed loans to redeploy capital into these stars and promising pilots-read on to see how these allocation choices shape risk, yield and long‑term value.

Crescent Capital BDC, Inc. (CCAP) - BCG Matrix Analysis: Stars

Stars

First Lien Software and Services Debt represents CCAP's largest industry exposure at 24% of the total investment portfolio as of December 2025, with a weighted average yield of 12.2% and a sector growth rate of 15% annually. High barriers to entry underpin a 98% first-lien security position across software-related holdings. These assets have been the primary driver of net investment income (NII) growth and maintain a dominant market share in middle‑market senior lending. Over the past twelve months CCAP allocated in excess of $200,000,000 of new capital to this high-growth segment to capitalize on accelerated digital transformation across target borrowers.

Metric Value
Portfolio Allocation (First Lien Software) 24%
Weighted Average Yield 12.2%
Software Market Growth Rate 15% p.a.
First‑Lien Coverage 98%
New Capital Allocated (last 12 months) $200,000,000+
Relative Market Position Dominant in middle‑market senior lending

Key strategic and credit characteristics for the First Lien Software segment include:

  • High current cash yield supporting immediate NII: 12.2% average coupon.
  • Strong credit protection: 98% first‑lien security reduces loss severity.
  • Sector growth tailwind: 15% CAGR providing revenue growth and refinancing optionality.
  • Substantial capital commitment: $200M+ deployed to expand market share and origination flow.

Unitranche Financing via Joint Ventures has expanded its asset base by 18% YoY, reaching a fair value of $450,000,000. The JV captures a high market share in a specialized mid‑market niche underserved by traditional banks. Return on equity (ROE) for this JV segment is 14.5%, outperforming the first-lien portfolio average. Market demand for blended, one‑stop financing solutions is increasing at approximately 10% per year. By employing a 2.0x leverage ratio within the JV, CCAP enhances ROI while retaining a senior structural position in the capital stack. The segment is capital intensive but offers superior risk‑adjusted returns relative to traditional mezzanine debt.

Metric Value
JV Unitranche Fair Value $450,000,000
YoY Asset Growth 18%
ROE (Segment) 14.5%
Market Demand Growth 10% p.a.
Leverage Ratio (JV) 2.0x
Capital Intensity High

Operational and risk considerations for Unitranche JVs include:

  • Enhanced yield profile versus senior-only loans (ROE 14.5%).
  • Leverage optimization (2.0x) amplifies returns while JV structure mitigates balance sheet concentration.
  • High market share in niche mid‑market where traditional lenders are retreating.
  • Increased operational oversight required due to capital intensity and credit monitoring needs.

Healthcare Technology and Services Portfolio now comprises 14% of CCAP's total portfolio value, targeting recession‑resilient sub‑sectors within healthcare IT and services. Interest income from this segment grew organically by 9.5% over the past fiscal year. The weighted average internal risk rating stands at 1.8 on a 5‑point scale, indicating strong credit quality. Market forecasts project the healthcare IT sector to expand by roughly 12% through 2026. CCAP maintains a 90% first‑lien concentration in this vertical and has committed over $220,000,000 in total capital to healthcare borrowers to secure a leading position in the space.

Metric Value
Portfolio Allocation (Healthcare Tech) 14%
Organic Interest Income Growth 9.5% (last fiscal year)
Weighted Avg. Internal Risk Rating 1.8 / 5
Healthcare IT Sector Growth 12% through 2026
First‑Lien Concentration 90%
Total Committed Capital $220,000,000+

Principal benefits and tactical priorities for the Healthcare Technology segment include:

  • Resilient cash flows and defensive characteristics during economic downturns.
  • Low credit volatility supported by a 1.8 average risk rating and 90% first‑lien protection.
  • Attractive growth runway (12% sector CAGR) for follow‑on investments and portfolio add‑ons.
  • Significant capital allocated ($220M+) to entrench market leadership and origination pipelines.

Crescent Capital BDC, Inc. (CCAP) - BCG Matrix Analysis: Cash Cows

Cash Cows

The Diversified Senior Secured First Lien Debt portfolio constitutes the principal cash-generating asset class for Crescent Capital BDC, representing 89% of total investment fair value as of Q4 2025. This core portfolio has a weighted average yield of 11.8% and a total fair value of approximately $1.65 billion, producing stable interest receipts that fund quarterly distributions. Non-accruals are exceptionally low at 0.5% at fair value, underscoring credit quality and income reliability. Minimal capital expenditure or reinvestment is required to sustain returns from this segment, which supplies the majority of the company's interest income and supports a dividend payout ratio of 92% of net investment income.

Metric Diversified Senior Secured First Lien Debt
Share of Portfolio (by fair value) 89%
Total Fair Value $1,650,000,000
Weighted Average Yield 11.8%
Non-Accrual Rate (at fair value) 0.5%
Contribution to Interest Income ~70-80% (company disclosure basis)
Dividend Payout Ratio (of NII) 92%
Reinvestment Requirement Low

Commercial Services and Supplies Investments form a mature, lower-growth segment making up 11% of the portfolio. This sector grows at an estimated 3% annually, producing a predictable interest stream with a weighted average yield of 11.5%. Holdings are structurally protected by a 100% first-lien position, reducing recovery uncertainty. Annual interest income from this segment exceeds $40 million, and current observed default risk is effectively zero. The company has maintained steady market share in this vertical for more than five years without material capital top-ups.

Metric Commercial Services & Supplies
Share of Portfolio (by fair value) 11%
Market Growth Rate 3% CAGR
Weighted Average Yield 11.5%
Security Position 100% First Lien
Annual Interest Income $40,000,000+
Default/Non-Accruals ~0% (current environment)
Capital Infusion Requirement Minimal

High Quality Consumer Services Debt accounts for approximately 7% of the portfolio and is characterized by high cash flow conversion and defensive credit metrics. The segment yields 11.9% on average, with market growth near 4% per year. Portfolio companies in this bucket report an average EBITDA margin of 25%, providing comfortable debt service coverage. Total exposure to this sector is maintained at $115 million to balance diversification and limit cyclicality risk. Low reinvestment requirements, strong historical recovery rates, and high cash conversion make this segment a reliable contributor to base dividend requirements.

Metric High Quality Consumer Services Debt
Share of Portfolio (by fair value) 7%
Total Exposure $115,000,000
Weighted Average Yield 11.9%
Market Growth Rate 4% CAGR
Average EBITDA Margin (portfolio companies) 25%
Reinvestment Requirement Low
Role in Dividend Support Buffer for base dividend
  • Primary cash drivers: First-lien senior secured debt (89% of fair value; $1.65B) with YA yield 11.8% and 0.5% non-accrual.
  • Stable secondary cash flows: Commercial services (11% of portfolio) yielding 11.5% and contributing $40M+ interest annually.
  • Defensive tertiary cash flows: Consumer services (7%; $115M exposure) yielding 11.9%, avg. EBITDA 25%.
  • Overall portfolio cash conversion supports a dividend payout ratio of ~92% of net investment income, with minimal capex/reinvestment needs for cash cow segments.

Crescent Capital BDC, Inc. (CCAP) - BCG Matrix Analysis: Question Marks

Dogs - Question Marks

Strategic Equity and Warrant Positions

Equity co-investments constitute approximately 4% of CCAP's total assets, representing $65.0 million of the portfolio. These positions target an internal rate of return (IRR) of 25%+ and are characterized by high upside potential and elevated exit timing uncertainty. Current Net Asset Value (NAV) per share is $20.15, and successful exits in this segment could meaningfully increase NAV. Annual private equity market growth is estimated at 12%, but valuation volatility requires ongoing mark-to-market monitoring and scenario-based stress testing.

Second Lien and Mezzanine Debt

Second lien and mezzanine exposures have been reduced to 2% of total assets. Yields on these positions exceed 14% on a coupon basis, with expected mezzanine market growth of ~8% in 2026 as interest-rate volatility subsides. Internal capital-charge models apply a ~50% premium to regulatory capital for these tiers, reflecting higher loss-given-default (LGD) and price volatility. Management has signaled a decision window spanning the next three vintage years to either scale this book or execute a strategic exit depending on realized vintage performance and default migration metrics.

Emerging Green Energy Financing

Green energy infrastructure lending is currently a pilot (<1% of assets, ~$15.0 million invested). The sector's compound annual growth rate (CAGR) is estimated at 20%, driven by federal tax credits and corporate ESG mandates. Initial yield on these pilot loans averages 12.5%. Long-term default correlation to traditional corporate credit is not yet statistically reliable given the small sample size; additional R&D and underwriting capacity will be required to compete with specialist green funds. Management is evaluating scalability, expected payback periods, and regulatory incentives for expansion.

Segment Allocation (% of Assets) Amount (USD) Target/Current Yield or IRR Sector Growth Expectation Risk Notes
Equity Co-Investments (Warrants) 4% $65,000,000 Target IRR ≥ 25% Private equity market ~12% p.a. High valuation volatility; long/uncertain exit timelines
Second Lien / Mezzanine 2% (~$32,500,000 assuming $1.625B AUM) Yield >14% Mezzanine market growth ~8% in 2026 Higher capital charge (+50%); speculative due to low market share
Green Energy Financing (Pilot) <1% $15,000,000 Yield ≈12.5% Sector CAGR ~20% Limited underwriting history; uncertain default correlations
Company NAV per Share $20.15 (current)

Key Operational and Risk Metrics

  • Total equity co-investment exposure: $65.0M (4% of assets)
  • Second lien / mezzanine allocation: 2% of assets; implied amount depends on AUM baseline
  • Green energy pilot: $15.0M (<1% of assets)
  • Target IRR for equity wins: ≥25%
  • Coupon/yield for mezzanine: >14%
  • Initial yield for green pilot: 12.5%
  • Private equity market growth assumption: 12% p.a.
  • Mezzanine market growth estimate (2026): 8%
  • Green sector CAGR estimate: 20% p.a.
  • Internal capital charge uplift for second lien/mezzanine: +50%

Strategic Considerations and Decision Triggers

  • Scale-up threshold for equity co-investments: additional $50-100M with demonstrated 18-24 month marked appreciation or exit pathway that supports ≥25% IRR.
  • Second lien/mezzanine review cadence: performance assessment across next three vintage years; exit if cumulative default rate > benchmark +200 bps or return-on-capital falls below targeted hurdle after capital charge.
  • Green financing go/no-go criteria: proven underwriting model, loss-rate sensitivity analysis, and public incentive stability for a minimum 5-year horizon prior to committing >2% of assets.
  • Valuation governance: quarterly fair-value reviews, independent 3rd-party appraisals on material positions, and scenario stress tests (base, downside, severe) to quantify NAV impact.

Crescent Capital BDC, Inc. (CCAP) - BCG Matrix Analysis: Dogs

Dogs - Non-Accrual and Distressed Assets

Non-accrual loans represent the underperforming portion of the portfolio, totaling 1.2% based on original cost and written down to 0.8% at fair value, reflecting a diminished recovery outlook and elevated credit impairment. These positions are concentrated in legacy industries experiencing an estimated -5% annual decline in market relevance. The modeled expected recovery rate for these distressed assets is 45% of original principal value, generating zero current return on invested capital while consuming disproportionate management time and legal/collection expenses. The company is pursuing secondary market sales and negotiated workouts to accelerate capital redeployment into higher-yielding segments.

Key metrics for Non-Accrual and Distressed Assets:

Metric Value
Share of Portfolio (original cost) 1.2%
Share of Portfolio (fair value) 0.8%
Modeled Recovery Rate 45%
Annual Market Relevance Change (sector) -5%
Current Yield on These Assets 0% (non-accrual)
Estimated Additional Management/Legal Cost ~0.15% of portfolio value annually

Management actions underway include:

  • Secondary market sales of select positions to realize current fair value.
  • Structured workouts and creditor negotiations to maximize recoveries toward the 45% modeled rate.
  • Reallocation of recovered capital into higher-growth, higher-yield credits.

Dogs - Legacy Retail and Consumer Discretionary

The legacy retail and consumer discretionary portfolio has declined to 3.0% of total assets as the firm pivots away from cyclical consumer exposure. This segment faces a negative market growth rate of -2.0% due to accelerating e-commerce penetration and secular shifts away from traditional brick-and-mortar business models. Weighted average yield on remaining retail loans has compressed to 9.5%, below the firm's target hurdle rate, while liquidity is low and sensitivity to consumer spending volatility is high. New capital deployment to this sector has ceased; existing loans are being allowed to run off or mature.

Metric Value
Share of Total Assets 3.0%
Market Growth Rate -2.0% annually
Weighted Average Yield 9.5%
Liquidity Profile Low
Strategy No new capital; run-off/maturity

Operational priorities for this segment:

  • Cease new originations and reallocate underwriting resources to higher-growth industries.
  • Monitor credit performance closely; accelerate dispositions when secondary pricing is favorable.
  • Manage maturities to minimize extension risk and interest-rate sensitivity.

Dogs - Underperforming Junior Debt Tranches

Remaining positions in third-party managed junior debt tranches constitute less than 1.5% of the portfolio. These holdings have produced a 4.0% total return over the past 24 months and have declined ~10% in fair value since inception, driven by widening credit spreads in the junior debt market and a structural shift toward unitranche financing. With no control over collateral or servicer decisions, the firm's ability to influence recoveries is limited. Management's intent is liquidation at or near par when market liquidity and pricing permit.

Metric Value
Share of Portfolio <1.5%
Return Last 24 Months 4.0%
Fair Value Decline Since Inception 10%
Market Trend Contraction due to unitranche adoption
Control Over Collateral Minimal

Disposition plan and risk mitigation:

  • Seek par or near-par exits via secondary sales as spreads tighten.
  • Monitor third-party manager performance and collate data to inform timing of exits.
  • Limit future exposure to non-control junior instruments; prefer structures with covenants or control rights.

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.